0.7020GBp+8.00%Mkt Cap: 4.08M GBpP/E: —Last update: 2026-06-01
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap4.08M GBp
Enterprise Value-1.71M GBp
Revenue (TTM)7.93M GBp
Gross Profit5.11M GBp
Net Income (TTM)-6.29M GBp
Revenue/Share0.0260 GBp
Last Price0.7020 GBp
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees14
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINGB0033278473
Valuation
P/E (Trailing)—
P/E (Forward)-0.87
PEG—
EV/EBITDA0.28
EV/Revenue-0.22
P/S0.48
P/B0.65
EPS (TTM)-0.03
EPS (Forward)-0.01
52W Range
0.60001% of range15.00
52W High15.00 GBp
52W Low0.6000 GBp
Profitability
Gross Margin64.49%
Oper. Margin-671.64%
EBITDA Margin-77.91%
Profit Margin-79.41%
ROE-115.97%
ROA-52.66%
Growth
Revenue Growth-85.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF391.47K GBp
CapEx (TTM)1.73M GBp
FCF Margin-20.41%
FCF Yield-39.64%
Net Debt-3.69M GBp
Net Debt/EBITDA0.60
Balance Sheet
Debt/Equity—
Current Ratio2.23
Quick Ratio2.11
Book Value/Sh0.0100 GBp
Cash/Share0.0120 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.581.33M
Float268.41M
Insiders16.13%
Institutions11.85%
Technical
SMA 500.9819 (-28.5%)
SMA 2002.330 (-69.9%)
Beta0.01
S&P 52W Chg27.94%
Avg Vol (30d)6.87M
Avg Vol (10d)3.63M
Technical Indicators
RSI (14)36.4
MACD-0.1072
MACD Signal-0.1163
MACD Hist.+0.0091
BB Upper0.8037 GBp
BB Middle0.7036 GBp
BB Lower0.6034 GBp
BB Width28.46%
ATR (14)0.1590 GBp
Vol Ratio (20d)0.23x